Two fighter suspensions were issued during the latest Nevada Athletic Commission meeting.
Bellator lightweight [autotag]Jay Jay Wilson[/autotag] and UFC women’s bantamweight [autotag]Irina Alekseeva[/autotag] both received suspensions for failed drug tests, the NAC announced Tuesday.
Wilson (10-1) tested positive for metenolone, an androgen and anabolic steroid prohibited on the World Anti-Doping Agency list, in a urine sample collected April 1 prior to his then-scheduled bout against Adam Piccolotti at 2024 PFL 2.
He was given a nine-month suspension retroactive to the date of the failed drug test and will be eligible to compete on Jan. 1, 2025. Wilson will also have to pay $157 in prosecution fees.
Alekseeva (5-1, 1-1 UFC) was given a 12-month suspension after testing positive for elevated testosterone, indicating exogenous administration, from a urine sample collected on June 21, 2023.
The suspension is retroactive to when she was notified about the failure, which came after a loss to Melissa Millins on Oct. 14, 2023 at a UFC Fight Night event. She’ll be eligible to compete again Oct. 15. On top of the suspension, Alekseeva was fined $157.
According to the UFC, former anti-doping partner U.S. Anti-Doping Agency handled Alekseeva’s drug test in an “unacceptable” manner that resulted in layers of confusion.
[lawrence-auto-related count=3 category=103]